22 min listen
NEJM Interview: Dr. Allison Goldfine on statins, the associated risk of diabetes, and the FDA's response.
FromNEJM Interviews
NEJM Interview: Dr. Allison Goldfine on statins, the associated risk of diabetes, and the FDA's response.
FromNEJM Interviews
ratings:
Length:
10 minutes
Released:
May 9, 2012
Format:
Podcast episode
Description
Dr. Allison Goldfine is the head of the Section of Clinical Research at Joslin Diabetes Center and an associate professor of medicine at Harvard Medical School. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. A.B. Goldfine. Statins: Is It Really Time to Reassess Benefits and Risks? N Engl J Med 2012;366:1752-5.
Released:
May 9, 2012
Format:
Podcast episode
Titles in the series (100)
NEJM Interview: Dr. Michael Barry on patient-centered care and shared decision making. by NEJM Interviews